Carroll et al. investigated in a retrospective single-center study in adult kidney transplant recipients the effect of peri-operative plasma exchange and candesartan in patients with high pre-transplant AT1R-Ab positivity and observed that this perioperative regimen may alter the risk of rejection compared to a historical control group [23], but further studies are needed. This evidence concerns the gene AGTR1 and medical procedure.